Home
Categories
Issues
2019
February 2019 - Vol 12 No 1
2018
November 2018 - Vol 11 No 3
August 2018 - Vol 11 No 2
May 2018 - Vol 11 No 1
2017
November Vol 10 No 4
August Vol 10 No 3
May Vol 10 No 2
February Vol 10 No 1
2016
November Vol 9 No 4
August Vol 9 No 3
May Vol 9 No 2
February Vol 9 No 1
Issue Archive
Media Library
Video Library
Audiocast Library
News
In the News
Press Releases
CE
Supplements
Resources
Online Only
Conference Correspondent
ASHP 2016 - Oncology
About
About
Advertise
Editorial Board
Contact Us
Links
Submit
Author Guidelines
Harris S. Goodman, MD
Medical Director, Clinical Laboratory
Saint Francis Memorial Hospital
San Francisco, CA
Authored Items
Ensuring Consistent and Reliable Biomarker Testing
Harris S. Goodman, MD
Faculty Perspectives–Rationale for PD-L1 Expression as a Biomarker in Immuno-Oncology | Part 2 of a 4-Part Series
Biomarkers and the Cancer Care Team: Critical Partners in Personalized Medicine
Harris S. Goodman, MD
Faculty Perspectives: An Overview of Existing and Emerging Biomarkers in Oncology | Part 1 of a 4-Part Series
Biomarkers and the Cancer Care Team: Critical Partners in Personalized Medicine
Harris S. Goodman, MD
Faculty Perspectives - An Overview of Existing and Emerging Biomarkers in Oncology | Part 1 of a 4-Part Series
Last modified: June 19, 2018
Home
Categories
Issues
2019
February 2019 - Vol 12 No 1
2018
November 2018 - Vol 11 No 3
August 2018 - Vol 11 No 2
May 2018 - Vol 11 No 1
2017
November Vol 10 No 4
August Vol 10 No 3
May Vol 10 No 2
February Vol 10 No 1
2016
November Vol 9 No 4
August Vol 9 No 3
May Vol 9 No 2
February Vol 9 No 1
Issue Archive
Media Library
Video Library
Audiocast Library
News
In the News
Press Releases
CE
Supplements
Resources
Online Only
Conference Correspondent
ASHP 2016 - Oncology
About
About
Advertise
Editorial Board
Contact Us
Links
Submit
Author Guidelines